When you think of high blood pressure, lifestyle choices around nutrition or exercise may come to mind—not your hormones. But what if we told you there's a sneaky hormone that could be driving your ...
AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...
US FDA approves AstraZeneca’s Baxfendy, an aldosterone synthase inhibitor to treat adults with hypertension: Cambridge, UK Wednesday, May 20, 2026, 10:00 Hrs [IST] AstraZenecas ...
Aldosterone is an important mediator in the pathogenesis of heart failure, and increased plasma aldosterone levels are associated with a poor prognosis. Aldosterone-receptor blocking drugs can slow ...
Oral presentation highlights efficacy and safety profile of lorundrostat in patients with uncontrolled hypertension and chronic kidney disease – RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Mineralys ...
May 30 (Reuters) - Mineralys Therapeutics' experimental drug significantly reduced blood pressure in patients with chronic kidney disease, according to new data presented at a major European medical ...
24d
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
NDA for lorundrostat in adults with hypertension accepted by FDA; assigned PDUFA target date of December 22, 2026 –– Conference call today at ...
A newly FDA approved drug offers a potential breakthrough for patients whose high blood pressure remains uncontrolled despite ...
The FDA has approved baxdrostat (Baxfendy), the first oral aldosterone synthase inhibitor, for adults with uncontrolled ...
May 2026 Baxfendyapproved in the US as the first and only aldosterone synthase inhibitortreatment for adults with hypertension Approval based on BaxHTN Phase III results showing statistically signific ...
- NDA for lorundrostat in adults with hypertension accepted by FDA; assigned PDUFA target date of December 22, 2026 - - Conference call today at 4:30 p.m. ET - RADNOR, Pa., May 06, 2026 (GLOBE ...
While lifestyle alterations have been previously recommended to control potassium levels for some patients with hyperkalemia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results